PubMed Kinesya E, Santoso D, Gde Arya N, et al
Ohanian M, Kantarjian HM, Ravandi F, Borthakur G, Garcia-Manero G, Andreeff M , Jabbour E, Konopleva M, Lim M, Pierce S, O'Brien S, Quintas-Cardama A, Somer BG, Tari A, Verstovsek S, Wierda WG, and Cortes JE
This is especially for people dealing with conditions like IBS, leaky gut, food intolerances, or autoimmune flare-ups
Its development marks a strategic pivot toward oral-first therapeutic models, potentially redefining the landscape of metabolic disease management while alleviating global supply chain limitations
Making food choices feels easier and less overwhelming
The results of this study likely highlight the importance of ongoing, individualized support for people managing obesity and type 2 diabetes